BC Investments IV, which owns 2,36,73,544 equity shares, or 13.07 per cent stake in Emcure Pharma, will be offloading the biggest chunk in the OFS component of the issue. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
